FIG. 1 · FIG. 1

Compounds and combinations thereof for treating neurological and psychiatric …

US12377091B2 · 08/05/2025 · 0 views

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Full text

3 sections

Abstract Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Official name

Compounds and combinations thereof for treating neurological and psychiatric …

Publication number

US12377091B2

Inventor / creator

Herriot Tabuteau

Assignee / owner

Antecip Bioventures Ii Llc

Filing

09/27/2024

Publication

08/05/2025

Expiry

09/27/2044

Status

ACTIVE

Open Google Patents →

No articles yet — metadata is still available from the registry.

Comments

0 replies · cite patents with ^

Guidelines

No comments yet.